Mode
Text Size
Log in / Sign up
N/A N=302 Randomized Single-blind Treatment

Communication and Coping for Mothers of Adolescents With Type 1 Diabetes

Type 1 Diabetes Mellitus

Enrolled (actual)
302
Serious AEs
3.3%
Results posted
Feb 2025
Primary outcome: Primary: Glycemic Control (A1C) — 8.4; 8.5 Percentage of glycated hemoglobin

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Communication & Coping Intervention (Behavioral); Education & Check Ins (Behavioral)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Vanderbilt University Medical Center
Primary completion
Aug 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Glycemic Control (A1C)
8.4; 8.5
SECONDARY
Maternal Depressive Symptoms
6.4; 5.1
SECONDARY
Mothers' Diabetes Distress
1.58; 1.72
SECONDARY
Adolescent Psychosocial Functioning - Parent Report
55.4; 57.3; 51.2; 52.4; 58.5; 60.8
SECONDARY
Adolescent Psychosocial Functioning - Self Report
53.6; 54.4; 48.9; 48.6; 58.5; 58.4
SECONDARY
Adolescent Quality of Life
67; 69
SECONDARY
Diabetes-related Family Conflict - Parent Report
28.2; 28.8
SECONDARY
Diabetes-related Family Conflict - Adolescent Report
30.1; 30.2
SECONDARY
Adolescent Diabetes Distress
74; 64
SECONDARY
Diabetes Knowledge
69; 82
SECONDARY
Parental Involvement
4.1; 4.0
SECONDARY
Adolescent Adherence
3.6; 3.7
SECONDARY
Quality of Parental Involvement
14.8; 13.1; 9.6; 9.9

Summary

Mothers of adolescents with type 1 diabetes experience high levels of depressive symptoms, which impair their ability to monitor and manage diabetes treatment effectively. Further, maternal depressive symptoms are one of the strongest predictors of negative outcomes in adolescents, including deteriorating glycemic control, problems with adherence, poorer quality of life, and greater risk for depression. Given that adolescents are a high-risk population for suboptimal glycemic control - with only 17% meeting treatment goals - there is a critical need for novel interventions to improve outcomes in adolescents with T1D. Yet, previous behavioral interventions for youth with diabetes have had only modest effects on glycemic control, and none have directly targeted maternal depressive symptoms. Building on effective interventions to treat depression in adults, and our own pilot work in this population, the proposed study will use a rigorous approach to evaluate the efficacy of a cognitive-behavioral intervention for mothers of adolescents with type 1 diabetes to promote the use of adaptive coping strategies and positive parenting practices. The aims of this study are to: 1) evaluate the effects of the Communication & Coping intervention on diabetes-related outcomes; 2) evaluate the effects of the Communication & Coping intervention on psychosocial outcomes; and 3) explore the differential impact of the intervention across demographic factors. Mothers who are randomized to the Communication & Coping Intervention will receive individual cognitive-behavioral therapy sessions by phone, as well as access to a Facebook group to augment the material covered in calls and provide social support. Mothers randomized to the Attention Control condition will receive educational materials and phone check-ins, as well as a Facebook group with educational posts. Adolescents and their mothers will be assessed at baseline and again post-intervention, at 3 months, 6 months, and 12 months.

Eligibility Criteria

Inclusion Criteria

  • Female caregiver of an adolescent with type 1 diabetes
  • Adolescent age 11-17
  • Adolescent diagnosed with type 1 diabetes for at least 12 months
  • Caregiver reports mild to moderate depressive symptoms (PHQ-9 score of 5-19) OR OR caregiver reports diabetes distress (Parent/Teen Relationship Distress Subscale score of 2 or higher)
  • English speaking

Exclusion Criteria

  • Caregiver reports minimal depressive symptoms (PHQ-9 score less than 5)
  • Caregiver reports severe depressive symptoms (PHQ-9 score 20 or higher)
  • Caregiver reports history of severe psychopathology (bipolar disorder or schizophrenia)
  • Caregiver reports that adolescent has history of severe psychopathology (bipolar disorder or schizophrenia)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03818711). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search